DaVita Market Cap 2010-2025 | DVA

DaVita market cap history and chart from 2010 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. DaVita market cap as of July 10, 2025 is $10.83B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.831B $12.816B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.140B 18.86
Encompass Health (EHC) United States $11.843B 25.10
Elanco Animal Health (ELAN) United States $7.470B 16.00
Chemed (CHE) United States $6.813B 21.41
Option Care Health (OPCH) United States $4.993B 22.25
RadNet (RDNT) United States $4.314B 273.81
Amedisys (AMED) United States $3.205B 21.56
Addus HomeCare (ADUS) United States $2.064B 22.67
LifeStance Health (LFST) United States $1.839B 0.00
Astrana Health (ASTH) United States $1.436B 35.57
U.S Physical Therapy (USPH) United States $1.159B 29.91
Pennant (PNTG) United States $0.890B 32.67
Aveanna Healthcare Holdings (AVAH) United States $0.825B 47.00
Atai Life Sciences (ATAI) Germany $0.547B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.038B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00